REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) Net income 2019–2025
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$19.9MFY2025 · since FY2019: $617,903 → -$19.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$19.9M | +33.6% |
| FY2024 | -$29.9M | +23.8% |
| FY2023 | -$39.3M | -38.9% |
| FY2022 | -$28.3M | -231.6% |
| FY2021 | -$8.5M | -125.2% |
| FY2020 | -$3.8M | -712.3% |
| FY2019 | $617,903 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RVPH financial trends
RVPH RevenueRVPH Net marginRVPH Gross profitRVPH Gross marginRVPH Operating incomeRVPH Operating marginRVPH Operating cash flowRVPH Free cash flowRVPH Capital expendituresRVPH Return on equityRVPH Stock buybacksRVPH Dividends paidRVPH Total assetsRVPH Total liabilitiesRVPH Shareholders’ equityRVPH overview →